Taiwan - Delayed Quote TWD

(030212.TW)

Compare

0.6100

-0.2500

(-29.07%)

At close: 1:24 PM GMT+8

Coursera, Norfolk Southern, CATL: Earnings in focus

Coursera (COUR) stock is sky-high Friday morning after beating second quarter earnings expectations. The online education company credits strong demand for its generative AI courses for the positive results. Norfolk Southern (NSC) stock is also rising following better-than-expected second-quarter earnings. The rail operator's cost-cutting efforts are showing progress and improving long-term margins in the wake of last year's train derailment in Palestine, Ohio. Contemporary Amperex Technology Co. (300750.SZ) reported a 13% jump in second quarter profit. However, the overall report was mixed for the Chinese EV battery developer with revenue declining due to weaker demand for electric vehicles (EVs). For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Angel Smith

Yahoo Finance Video 7 minutes ago

300750.SZ

NSC

COUR
3M stock jumps on Q2 results, earnings guidance boost

Shares of 3M (MMM) rose more than 15% early Friday after raising the low end of its full-year adjusted earnings guidance and reporting second quarter sales that came in above expectations. Morning Brief Hosts Jared Blikre and Seana Smith break down the company's second quarter earnings and its performance under its new CEO, Bill Brown. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Melanie Riehl

Yahoo Finance Video 50 minutes ago

MMM
June PCE, Bristol Myers Squibb earnings: What to watch Friday

Asking for a Trend Host Josh Lipton breaks down what to watch on Friday, July 26th. Personal Consumption Expenditures (PCE) data — the Federal Reserve's preferred inflation gauge — will be released at 8:30 a.m. ET. Economists expect both overall PCE and core PCE to slightly rise in June. Bristol Myers Squibb (BMY), Colgate-Palmolive (CL), Aon (AON), and 3M (MMM) are expected to report their earnings. Finally, the summer box office will heat up with the release of "Deadpool & Wolverine." The new Marvel movie is expected to bring in between $160 to $170 million domestically. For more expert insight and the latest market action, click here to watch this full episode of Asking For A Trend. This post was written by Melanie Riehl

Yahoo Finance Video 17 hours ago

BMY

CELG-RT

AON
OpenAI announces testing of new search engine, SearchGPT

OpenAI — which Microsoft (MSFT) owns a 49% stake in — is stepping into the search engine game. In a move that could rival Alphabet's (GOOG, GOOGL) Google search, the artificial intelligence developer unveiled its SearchGPT engine. The Market Domination team analyzes OpenAI's blog post outlining what it hopes to achieve in this search platform. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 19 hours ago

GOOG

MSFT
The next big hurdle for hot tech stocks like Nvidia

Though AI-related stocks like Nvidia (NVDA) continue to grow exponentially, market strategists like Morgan Stanley Chief US Equity Strategist & CIO Mike Wilson speculate whether the technology really aligns with the revenue and earnings. "I think we're entering the dangerous part of the story where we need to see the numbers," Wilson said when he spoke with Yahoo Finance Executive Editor Brian Sozzi on Opening Bid. For full episodes of Opening Bid, watch on our website or listen on your favorite podcast platform.

Yahoo Finance Video 21 hours ago

NVDA

CRM

GOOG
Google makes its Gemini chatbot faster and more widely available

In its bid to maintain pace with generative AI rivals like Anthropic and OpenAI, Google is rolling out updates to the no-fee tier of Gemini, its AI-powered chatbot. The updates are focused on making the platform more performant -- and more widely available. Starting Thursday, Gemini 1.5 Flash -- a lightweight multimodal model Google announced in May -- will be available on the web and mobile in 40 languages and around 230 countries. Google claims that Gemini 1.5 Flash delivers upgrades in qualit

TechCrunch 23 hours ago

GOOG
John Malone’s Media Empire Has Hit a Rough Patch

John Malone’s sprawling media empire faces big challenges. Here’s what happened—and what investors should do now.

Barrons.com 7 minutes ago

SIRI

LBRDK

QRTEB
Charter Communications Stock Pacing for Best Day on Record After Earnings. Here’s Why.

Shares of Charter Communications were on pace for their best day on record after the cable giant turned in a strong quarterly report. The company—which offers pay TV services and Spectrum internet—posted second-quarter earnings of $8.49 per share, beating Wall Street’s call for $7.98, according to FactSet. Revenue of $13.69 billion was above the $13.59 billion analysts had penciled in “driven by growth in residential mobile service, residential Internet, enterprise and other revenues, partly offset by lower residential video revenue,” according to the company.

Barrons.com 8 minutes ago

CHTR
Google to blame for slower YouTube speeds in Russia, says senior lawmaker

Russia has criticised Alphabet's Google for taking down YouTube channels of Russian media and public figures and fined the U.S. company several times for failing to remove content Russia considers illegal or undesirable. Alexander Khinshtein, head of the lower house of parliament's information policy committee, on Thursday said slower speeds on the video hosting site was a forced step directed against YouTube for believing it could violate Russian law without punishment.

Reuters 8 minutes ago

GOOG
Bristol Myers Stock Rises Sharply. A Sales Jump for Eliquis Boosts Earnings.

Global sales of Eliquis, a drug used to reduce the risk of stroke and blood clots, increase 7% in the second quarter from a year earlier.

Barrons.com 12 minutes ago

CELG-RT
EU Rejection of Alzheimer’s Drug Is Another Disappointment for Biogen

European drug regulators rejected Biogen and Eisai request for approval of their Alzheimer’s medicine Leqembi, pointing to safety and efficacy issues that U.S. regulators looked past when they granted the drug full approval last year. The European Medicines Agency said Friday that it had recommended to the European Commission that it refuse marketing authorization within the European Union for Leqembi because of the drug’s limited benefits and the significant risks associated with it. “The observed effect of Leqembi on delaying cognitive decline does not counterbalance the risk of serious adverse events associated with the medicine,” the EMA said in a new document.

Barrons.com 20 minutes ago

BIIB
Bristol Myers Retakes Its 200-Day Line On Quarterly Beat, Surprise Immunology Win

Bristol Myers Squibb stock gapped higher Friday after the Big Pharma stalwart beat June-quarter forecasts and raised its outlook.

Investor's Business Daily 21 minutes ago

CELG-RT
Why DexCom Stock Is Crashing Today

Investors are worried about the diabetes care technology leader's slowing growth.

Motley Fool 26 minutes ago

DXCM
Bristol-Myers Squibb Beats Q2 Expectations, Boosts Guidance on Rising Drug Sales

Bristol-Myers Squibb shares climbed Friday after the company beat second-quarter expectations and raised its full-year guidance.

Investopedia 32 minutes ago

CELG-RT
These Stocks Are Moving the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, and More

DexCom falls sharply after cutting its fiscal-year sales forecast, 3M and Bristol Myers surge after the companies post better-than-forecast earnings, and Biogen tumbles after European regulators reject its Alzheimer's treatment.

Barrons.com 32 minutes ago

GOOG

DXCM

F
Coursera Stock Soars 46% After Earnings. AI Gives Revenue a Sharp Boost.

Coursera stock was surging Friday after the online learning platform posted a surprise earnings and revenue beat as millions enrolled for its generative artificial-intelligence courses. Coursera reported adjusted earnings of 9 cents a share, which beat analysts’s expectations of 1 cent. Revenue for the quarter of $170.3 million also came in above estimates of $164.7 million and increased 11% from the same period last year. “We are excited to surpass more than two million enrollments in our generative AI catalog of courses, credentials, and hands-on projects created by the world’s top technology companies and research universities,” Chief Executive Jeff Maggioncalda.

Barrons.com 33 minutes ago

COUR
3M Wants to Speed New Product Launches; Stock Rockets After Earnings

3M’s new chief executive says he wants the materials company to improve its innovation process by being more strategic and efficient and accelerating the introduction of new products. “Those are the things I'll be looking at to try to develop more growth coming out of the R&D investment,” said Bill Brown, who took over from Mike Roman in May. His comments came as 3M boosted the floor of its full-year outlook following a quarter in which it beat analysts’ expectations for sales and earnings. 3M shares (MMM) rallied more than 16%.

The Wall Street Journal 33 minutes ago

MMM
Why Coursera Stock Exploded 51% Higher Today

Coursera is generating a lot of free cash flow, and its stock might be a buy.

Motley Fool 39 minutes ago

COUR
These Stocks Are Moving the Most Today

DexCom falls sharply after cutting its fiscal-year sales forecast, 3M and Bristol Myers surge after the companies post better-than-forecast earnings, and Biogen tumbles after European regulators reject its Alzheimer's treatment.

Barrons.com 43 minutes ago

DXCM

DECK
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events

On Friday, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a negative opinion on the approval of Eisai Co., Ltd (OTC:ESALY) (OTC:ESALF) and Biogen Inc.’s (NASDAQ:BIIB) lecanemab. The companies seek approval for the humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody as a treatment for early AD (mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD). The committee considered that the observed effect of Le

Benzinga 47 minutes ago

BIIB

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

(030212.TW)

Related News

Coursera, Norfolk Southern, CATL: Earnings in focus

3M stock jumps on Q2 results, earnings guidance boost

June PCE, Bristol Myers Squibb earnings: What to watch Friday

OpenAI announces testing of new search engine, SearchGPT

The next big hurdle for hot tech stocks like Nvidia

Google makes its Gemini chatbot faster and more widely available

John Malone’s Media Empire Has Hit a Rough Patch

Charter Communications Stock Pacing for Best Day on Record After Earnings. Here’s Why.

Google to blame for slower YouTube speeds in Russia, says senior lawmaker

Bristol Myers Stock Rises Sharply. A Sales Jump for Eliquis Boosts Earnings.

EU Rejection of Alzheimer’s Drug Is Another Disappointment for Biogen

Bristol Myers Retakes Its 200-Day Line On Quarterly Beat, Surprise Immunology Win

Why DexCom Stock Is Crashing Today

Bristol-Myers Squibb Beats Q2 Expectations, Boosts Guidance on Rising Drug Sales

These Stocks Are Moving the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, and More

Coursera Stock Soars 46% After Earnings. AI Gives Revenue a Sharp Boost.

3M Wants to Speed New Product Launches; Stock Rockets After Earnings

Why Coursera Stock Exploded 51% Higher Today

These Stocks Are Moving the Most Today

Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events